Carrot and stick: HIF-alpha engages c-Myc in hypoxic adaptation

Cell Death and Differentiation
L E Huang

Abstract

The past decade of research on hypoxic responses has provided a considerable understanding of how cells respond to hypoxic stress at the molecular level, thanks to the identification and molecular cloning of the hypoxia-inducible transcription factor, HIF-1alpha. Numerous target genes have since been identified to account for various aspects of the hypoxic response, including angiogenesis and glycolysis. Yet, fundamental questions remain regarding the mechanisms by which hypoxia controls cell proliferation, genetic instability, mitochondrial biogenesis, and oxidative respiration in cancer cells. Although the proto-oncoprotein c-Myc appears to be the diametrical opposite of HIF-1alpha in most of these processes, recent studies indicate that c-Myc is an integral part of the HIF-alpha-c-Myc molecular pathway in the hypoxic response. It has been shown that HIF-alpha engages with Myc by various mechanisms to achieve oxygen homeostasis for cell survival. This article focuses on the intricate roles of c-Myc in the hypoxic response, discusses various mechanisms controlling c-Myc activity by HIF-alpha for the regulation of hypoxia-responsive genes, and emphasizing the outcome of gene expression apparently dependent upon hypoxic conditio...Continue Reading

References

Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·G L WangG L Semenza
Jan 20, 1995·The Journal of Biological Chemistry·G L Wang, G L Semenza
Nov 12, 1996·Proceedings of the National Academy of Sciences of the United States of America·Z AranyD M Livingston
Jan 10, 1997·The Journal of Biological Chemistry·B L Booth, B F Pugh
Apr 25, 1997·The Journal of Biological Chemistry·C W PughP J Ratcliffe
Aug 15, 1997·Genes & Development·E ZelzerB Z Shilo
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·L E HuangH F Bunn
Dec 22, 1998·Molecular and Cellular Biology·C V Dang
Feb 26, 1999·The Journal of Biological Chemistry·P J KallioL Poellinger
Oct 14, 2000·Annual Review of Cell and Developmental Biology·C GrandoriR N Eisenman
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·F YuF S Lee
Oct 13, 2001·Science·R K Bruick, S L McKnight
Feb 2, 2002·Science·David LandoMurray L Whitelaw
Mar 21, 2002·Nature Reviews. Cancer·Adrian L Harris
Dec 17, 2002·Molecular and Cellular Biology·Nobuhito GodaRandall S Johnson
Sep 18, 2003·Nature Reviews. Cancer·Gregg L Semenza
Oct 4, 2003·Nature Reviews. Drug Discovery·Amato GiacciaRandall S Johnson
Apr 9, 2004·The EMBO Journal·Minori KoshijiL Eric Huang
Jun 11, 2004·Cell Cycle·Minori Koshiji, L Eric Huang
Jun 15, 2005·Annual Review of Biochemistry·William G Kaelin
Jun 23, 2005·Cell Cycle·Kenneth K W ToL Eric Huang
Aug 3, 2005·Nature Reviews. Molecular Cell Biology·Sovana Adhikary, Martin Eilers

❮ Previous
Next ❯

Citations

Sep 11, 2012·Langenbeck's Archives of Surgery·Martin MollenhauerMartin Schneider
Nov 26, 2009·Molecules and Cells·Young-Suk ChoJong-Wan Park
Nov 13, 2009·Nature Reviews. Cancer·Tracy A Brooks, Laurence H Hurley
Sep 15, 2011·The Journal of Biological Chemistry·Cecilia M DevlinIrina Petrache
Mar 16, 2013·Science·L Eric Huang
Mar 24, 2009·American Journal of Physiology. Lung Cellular and Molecular Physiology·Kelly SchultzDebbie Beasley
Jan 1, 2010·Cancer Management and Research·Christopher Rice, L Eric Huang
Oct 23, 2012·Journal of Neurosurgery. Pediatrics·Eric M ThompsonEdward A Neuwelt
Jun 10, 2014·Critical Reviews in Oncology/hematology·Nada Al HasawiYunus A Luqmani
Jun 25, 2014·Mitochondrion·Marco TomasettiLanfeng Dong
Dec 3, 2014·FEBS Letters·Katrin Kemmerer, Julia E Weigand
Mar 1, 2013·Expert Opinion on Therapeutic Targets·George S KrasnovAnna V Kudryavtseva
Dec 17, 2009·Connective Tissue Research·Patrizia CancemiIda Pucci-Minafra
Dec 8, 2015·Experimental and Therapeutic Medicine·Theodoros EleftheriadisIoannis Stefanidis
May 7, 2010·Bone·Elisa Araldi, Ernestina Schipani
Dec 1, 2009·The International Journal of Biochemistry & Cell Biology·Athanassios VassilopoulosTriantafyllos Chavakis
May 21, 2009·Experimental and Molecular Pathology·Abdullah YalcinJason Chesney
Nov 29, 2008·Free Radical Biology & Medicine·Enrique SamperSimon Melov
Jul 17, 2015·Cancer Biology & Therapy·Karin Melanie Cabanillas StanchiUrsula Holzer
Oct 23, 2009·Annals of the New York Academy of Sciences·Young-Gun YooL Eric Huang
May 1, 2012·Pediatric Blood & Cancer·Amal El NaggarPoul H Sorensen
Mar 20, 2010·Journal of Cellular Physiology·Antero Salminen, Kai Kaarniranta
Oct 14, 2014·The American Journal of Pathology·Yan ZhouEmin Maltepe
Sep 11, 2013·Biochimica Et Biophysica Acta·Marco TomasettiLanfeng Dong
May 23, 2015·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Helena DoktorovaTomas Eckschlager
Feb 11, 2015·Biochimica Et Biophysica Acta·Viswanath DasJohn H Miller
Oct 18, 2013·Cell Adhesion & Migration·Tianyu HanJian-Bin Wang
Mar 31, 2012·Seminars in Cancer Biology·Eric RaspeGeert Berx
Mar 6, 2013·Biochimica Et Biophysica Acta·Aggeliki LyberopoulouEleni Georgatsou
Jun 10, 2014·Cancer Letters·Biswa Pratim Das Purkayastha, Jagat Kumar Roy
Jul 31, 2016·Experimental Physiology·Eoin P Cummins, Ciara E Keogh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.